非酒精性脂肪性肝病患者非酒精性肝炎的早期诊断
Early Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
DOI: 10.12677/ACM.2022.122143, PDF,   
作者: 李露文：西安医学院，陕西 西安；姬新才：陕西省人民医院，陕西 西安
关键词: 非酒精性脂肪性肝病；非酒精性肝炎；早期诊断；Non-Alcoholic Fatty Liver Disease； Nonalcoholic Steatohepatitis； Early Diagnosis
摘要: 随着医疗技术的不断进步和人民生活方式的改变，全球慢性肝病的病因谱已经发生了巨大变化。非酒精性脂肪性肝病(Non-alcoholic fatty liver disease, NAFLD)呈全球流行趋势，已经成为日益增长的肝硬化和肝癌的致病原因之一，严重威胁着人类的生命健康。本综述旨在介绍非酒精性脂肪性肝病患者非酒精性肝炎的早期诊断方法，从而为更好地预防和控制疾病起到指导作用。
Abstract: With the continuous progress of medical technology and the change of people’s lifestyle, the etiological spectrum of chronic liver disease in the world has changed greatly. Non-alcoholic fatty liver disease (NAFLD) is a global epidemic and has become one of the causes of increasing liver cirrhosis and liver cancer, which is a serious threat to human life and health. The purpose of this review is to introduce the early diagnosis of non-alcoholic hepatitis in patients with non-alcoholic fatty liver disease, so as to provide guidance for better disease prevention and control.
文章引用：李露文, 姬新才. 非酒精性脂肪性肝病患者非酒精性肝炎的早期诊断[J]. 临床医学进展, 2022, 12(2): 986-990. https://doi.org/10.12677/ACM.2022.122143

参考文献

[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版) [J]. 中华肝脏病杂志, 2018, 26(3): 195-203. [Google Scholar] [CrossRef] 
[2] Manne, V., Handa, P. and Kowdley, K.V. (2018) Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease, 22, 23-37.
[3] 姜煜资, 聂红明, 汪蓉. 非酒精性脂肪性肝病的发病机制[J]. 临床肝胆病杂志, 2019, 35(11): 2588-2591. [Google Scholar] [CrossRef] 
[4] Sookoian, S. and Pirola, C.J. (2017) Genetic Predisposition in Nonalcoholic Fatty Liver Disease. Clinical and Molecular Hepatology, 23, 1-12. [Google Scholar] [CrossRef] [PubMed]
[5] Younossi, Z., Anstee, Q.M., Marietti, M., et al. (2018) Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 15, 11-20. [Google Scholar] [CrossRef] [PubMed]
[6] Younossi, Z., Koenig, A.B., Abdelatif, D., et al. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84.
[7] Fan, J.G. (2013) Epidemiology of Alcoholic and Nonalcoholic Fatty Liver Disease in China: Fatty Liver in China. Journal of Gastroenterology and Hepatology, 28, 11-17.
[8] Pais, R., Barritt, A.S., Calmus, Y., et al. (2016) NAFLD and Liver Transplantation: Current Burden and Expected Challenges. Journal of Hepatology, 65, 1245-1257.
[9] Younossi, Z., Tacke, F., Arrese, M., et al. (2019) Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Hepatology. Hepatology, 69, 2672-2682.
[10] Feldstein, A.E., Wieckowska, A., Lopez, A.R., et al. (2009) Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study. Hepatology, 50, 1072-1078.
[11] Vilar-Gomez, E. and Chalasani, N. (2018) Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Clinical Prediction Rules and Blood-Based Biomarkers. Journal of Hepatology, 68, 305-315. [Google Scholar] [CrossRef] [PubMed]
[12] Palekar, N.A., Naus, R., Larson, S.P., et al. (2006) Clinical Model for Distinguishing Nonalcoholic Steatohepatitis from Simple Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Liver International, 26, 151-156.
[13] Gholam, P.M., Flancbaum, L., Machan, J.T., et al. (2007) Nonalcoholic Fatty Liver Disease in Severely Obese Subjects. American Journal of Gastroenterology, 102, 399-408. [Google Scholar] [CrossRef] [PubMed]
[14] Feldstein, A.E., Lopez, R., Tamimi, T.A.R., et al. (2010) Mass Spectrometric Profiling of Oxidized Lipid Products in Human Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Journal of Lipid Research, 51, 3046-3054. [Google Scholar] [CrossRef] 
[15] Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., et al. (2011) A Simple Clinical Scoring System Using Ferritin, Fasting Insulin, and Type IV Collagen 7S for Predicting Steatohepatitis in Nonalcoholic Fatty Liver Disease. Journal of Gastroenterology, 46, 257-268. [Google Scholar] [CrossRef] [PubMed]
[16] Newsome, P.N., Sasso, M., Deeks, J.J., et al. (2020) FibroScan-AST (FAST) Score for the Non-Invasive Identification of Patients with Non-Alcoholic Steatohepatitis with Significant Activity and Fibrosis: A Prospective Derivation and Global Validation Study. The Lancet Gastroenterology & Hepatology, 5, 362-373. [Google Scholar] [CrossRef] 
[17] Harrison, S.A., Ratziu, V., Boursier, J., et al. (2020) A Blood-Based Biomarker Panel (NIS4) for Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis and Liver Fibrosis: a Prospective Derivation and Global Validation Study. The Lancet Gastroenterology & Hepatology, 5, 970-985. [Google Scholar] [CrossRef] 
[18] Hernaez, R., Lazo, M., Bonekamp, S., et al. (2011) Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis. Hepatology, 54, 1082-1090.
[19] Dietrich, C., Bamber, J., Berzigotti, A., et al. (2017) EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in der Medizin, 38, 377-394. [Google Scholar] [CrossRef] [PubMed]
[20] Friedrich-Rust, M., Poynard, T. and Castera, L. (2016) Critical Comparison of Elastography Methods to Assess Chronic Liver Disease. Nature Reviews Gastroenterology & Hepatology, 13, 402-411. [Google Scholar] [CrossRef] [PubMed]
[21] Ferraioli, G., Wong, V.W.S., Castera, L., et al. (2018) Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound in Medicine & Biology, 44, 2419-2440. [Google Scholar] [CrossRef] [PubMed]
[22] Eddowes, P.J., Sasso, M., Allison, M., et al. (2019) Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology, 156, 1717-1730. [Google Scholar] [CrossRef] [PubMed]
[23] Khalifa, A. and Rockey, D.C. (2020) The Utility of Liver Biopsy in 2020. Current Opinion in Gastroenterology, 36, 184-191. [Google Scholar] [CrossRef] 
[24] Boyd, A., Cain, O., Chauhan, A., et al. (2020) Medical Liver Biopsy: Background, Indications, Procedure and Histopathology. Frontline Gastroenterology, 11, 40-47. [Google Scholar] [CrossRef] [PubMed]
[25] Segovia-Miranda, F., Morales-Navarrete, H., Kücken, M., et al. (2019) Three-Dimensional Spatially Resolved Geometrical and Functional Models of Human Liver Tissue Reveal New Aspects of NAFLD Progression. Nature Medicine, 25, 1885-1893. [Google Scholar] [CrossRef] [PubMed]

为你推荐